NCT03084783

Dexamethasone in Herpes Simplex Virus Encephalitis

Dexamethasone in Herpes Simplex Virus Encephalitis Open Label Randomized Controlled Trial With an Observer-blinded Evaluation at 6 Months

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University Hospital, Grenoble · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Encephalitics is a serious condition in which the brain becomes inflamed (swollen). It usually happens as a direct result of virus, such as herpes simplex virus (HSV). HSV encephalitis is often treated with the drug acyclovir (an antiviral drug which slows the growth and spread of HSV in the body). Despite this however, around 2 out of every 3 people will have memory difficulties long term. Dexamethasone is a corticosteroid medication, which works by preventing the release of natural chemicals in the body which cause inflammation. It is possible that dexamethasone could help to reduce in swelling of the brain may improve the recovery of patients with HSV encephalitis. The aim of this study is to find out whether treatment with dexamethasone can improve long-term health outcomes in adults with HSV Encephalitis.

Conditions

• HSV Encephalitis

Interventions

Type	Name	Description
DRUG	Dexamethasone	Participants receive dexamethasone 10mg intravenously 6 hourly for 4 days.

Timeline

• Start date: 2018-11-01
• Primary completion: 2020-11-01
• Completion: 2020-12-01
• First posted: 2017-03-21
• Last updated: 2020-09-04

Locations

8 sites across 1 country: France